fda glp-1 compounding crackdown october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The FDA just signaled a

Various authors

[3] If more time has passed than these windows, skip that dose entirely and resume with your next scheduled injection

Better long-term adherence because hunger is reduced, making nutrition plans easier to follow

J Basic Appl Zool

Evidence suggests multiple interrelated pathways of liver injury: Nicotine-induced injury : Nicotine is metabolized in the liver via CYP2A6, where it activates 7-nicotinic acetylcholine receptors (7-nAChR), leading to oxidative stress, mitochondrial dysfunction, and pro-fibrotic signaling [36, 125, 126]

Liraglutide reduced this renal outcome by 22% after 3.8 years follow up, whereas semaglutide showed a reduction of 36% after 2.1 years